Search research articles
Contact Us
Filters
Showing results (241-250 of 635) with videos related to
Page
of 64
Sort By:
European Heart Journal
|
April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
Circulation. Cardiovascular Interventions
|
June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology
|
February 6, 2016
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial
Tannas Jatene, Robert A Harrington, Gregg W Stone, et al.
Clinical Cardiology
|
June 13, 2017
Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort
Jessie Kittle, Renato D Lopes, Mingyan Huang, et al.
Contemporary Clinical Trials
|
January 12, 2011
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Kenneth W Mahaffey, June L Wampole, Amanda Stebbins, et al.
The American Journal of Cardiology
|
August 14, 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX)
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of Thrombosis and Thrombolysis
|
May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Dominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.
Kidney International Reports
|
February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE Trial
Akihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Circulation. Cardiovascular Interventions
|
October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial
Aman Kansal, Zhen Huang, Frank W Rockhold, et al.
Page
of 64
Search research articles
Search
Showing results (241-250 of 635) with videos related to
Sort By:
Page
of 64
European Heart Journal
|
April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
Circulation. Cardiovascular Interventions
|
June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology
|
February 6, 2016
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial
Tannas Jatene, Robert A Harrington, Gregg W Stone, et al.
Clinical Cardiology
|
June 13, 2017
Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort
Jessie Kittle, Renato D Lopes, Mingyan Huang, et al.
Contemporary Clinical Trials
|
January 12, 2011
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Kenneth W Mahaffey, June L Wampole, Amanda Stebbins, et al.
The American Journal of Cardiology
|
August 14, 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX)
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of Thrombosis and Thrombolysis
|
May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Dominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.
Kidney International Reports
|
February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE Trial
Akihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The Lancet. Diabetes & Endocrinology
|
October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Megumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Circulation. Cardiovascular Interventions
|
October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial
Aman Kansal, Zhen Huang, Frank W Rockhold, et al.
Page
of 64